EUCLIDEAN CAPITAL LLC – NGM Biopharmaceuticals, Inc. Transaction History
EUCLIDEAN CAPITAL LLC portfolio value:
$9.76M
portfolio value
EUCLIDEAN CAPITAL LLC quarter portfolio value change:
+2.03%
quarter
NGM Biopharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 194K | $13.08 | 746.67K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.81M | $12.82 | 746.67K | |
| Q1 2022 | share | 0.00% | 0 shares | -1.83M | $15.25 | 746.67K | |
| Q4 2021 | share | Decrease | -10.29% | -85.6K shares | -4.27M | $17.56 | 746.67K |
| Q3 2021 | share | Decrease | -44.27% | -661.07K shares | -11.95M | $21.02 | 832.27K |
| Q2 2021 | share | 0.00% | 0 shares | -13.96M | $19.72 | 1.49M | |
| Q1 2021 | share | Decrease | -28.33% | -590.25K shares | -19.72M | $29.07 | 1.49M |
| Q4 2020 | share | Increase | 0.00% | 2.08M shares | 63.13M | $30.3 | 2.08M |